Choksi Asia Ltd vs Nath Bio Genes India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 22, 2026

Key Highlights

The Latest Trading Price of Choksi Asia Ltd is ₹ 148 as of 18 Jun 16:01 . The P/E Ratio of Choksi Asia Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 7.2 on March 2025 . This represents a CAGR of -2.21% over 3 years The Market Cap of Choksi Asia Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 277.17 crore on March 2025 . This represents a CAGR of -9.07% over 4 years The revenue of Choksi Asia Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The ebitda of Choksi Asia Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The net profit of Choksi Asia Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The Dividend Payout of Choksi Asia Ltd changed from 51.05 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Choksi Asia Ltd

Choksi Asia Limited was initially established as 'Selvas Photographics Limited' in 1992.
The name of the Company was changed from Selvas Photographics Limited to Choksi Imaging Limited in June, 2004 and further has changed the name of the Company to Choksi Asia Limited on May 25, 2025. Company was promoted by CHOKSI Family, who started trading and import of Photographies material in 1924 at Bombay.
At present, Company manufactures Photosensitised Materials for Photographic Industry viz.
X-Ray Films, which are used by the Radiologists, Doctors in private clinics, Hospitals and Industrial Radiographers. The company went for expansion in respect of x-ray films in 1996.It has increased installed capacity of x-ray films from 7.50 lakhs sq.mtr(SQM) to 16.50 lakhs sq.mtr. The company started producing another product,Photographic Colour Paper,during 1999-2000.

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

FAQs for the comparison of Choksi Asia Ltd and Nath Bio-Genes (India) Ltd

Which company has a larger market capitalization, Choksi Asia Ltd or Nath Bio-Genes (India) Ltd?

Market cap of Choksi Asia Ltd is 128 Cr while Market cap of Nath Bio-Genes (India) Ltd is 288 Cr

What are the key factors driving the stock performance of Choksi Asia Ltd and Nath Bio-Genes (India) Ltd?

The stock performance of Choksi Asia Ltd and Nath Bio-Genes (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Choksi Asia Ltd and Nath Bio-Genes (India) Ltd?

As of September 22, 2026, the Choksi Asia Ltd stock price is INR ₹226.0. On the other hand, Nath Bio-Genes (India) Ltd stock price is INR ₹152.0.

How do dividend payouts of Choksi Asia Ltd and Nath Bio-Genes (India) Ltd compare?

To compare the dividend payouts of Choksi Asia Ltd and Nath Bio-Genes (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.